Andrx Generic Zyban/Wellbutrin SR To Be Approved Mid-Year After Patent Win

Andrx' generic version of GlaxoSmithKline's Wellbutrin SR and Zyban (bupropion sustained release) is expected to be approved by mid-year following a Feb. 28 patent ruling

More from Archive

More from Pink Sheet